NutriBand (NTRB) Shares Outstanding (2016 - 2026)
NutriBand (NTRB) posted Shares Outstanding (Entity) of $12.2 million for Q2 2026, little changed sequentially from $12.2 million in Q1 2026, and up 77.92% YoY from $6.8 million in Q2 2025.
NutriBand (NTRB) Shares Outstanding (2016 - 2026) Analysis & Trends
NutriBand has reported Shares Outstanding (Entity) for 11 years, with the latest figure at $12.2 million in Q2 2026.
- Quarterly Shares Outstanding (Entity) rose 77.92% year-over-year to $12.2 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $12.2 million (up 77.92% YoY) and the FY2026 annual result came in at $12.2 million, up 9.76% from the prior year.
- Shares Outstanding (Entity) steadied at $12.2 million in Q2 2026 per NTRB's latest filing, from $12.2 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $12.2 million in Q4 2025 and troughed at $6.7 million in Q2 2024.
- A 5-year average of $9.4 million and a median of $9.0 million in 2022 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) dropped 14.4% in 2023, then jumped 77.92% in 2026.
- Over 5 years, Shares Outstanding (Entity) stood at $7.8 million in 2022, then increased by 0.38% to $7.8 million in 2023, then soared by 41.78% to $11.1 million in 2024, then increased by 9.45% to $12.2 million in 2025, then changed by 0.0% to $12.2 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $12.2 million, $12.2 million, and $12.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 133.61 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 217.35 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 445.06 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 241.70 Mn |
| 10 | NutriBand | 46.38 Mn | 42.37 Mn | 196,801.00 | 12.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 12.16 Mn |
| Jan 31, 2026 | 11.64 Mn |
| Oct 31, 2025 | 12.06 Mn |
| Jul 31, 2025 | 11.22 Mn |
| Apr 30, 2025 | 6.83 Mn |
| Jan 31, 2025 | 10.61 Mn |
| Oct 31, 2024 | 11.10 Mn |
| Jul 31, 2024 | 11.06 Mn |
| Apr 30, 2024 | 6.75 Mn |
| Jan 31, 2024 | 7.95 Mn |
| Oct 31, 2023 | 7.83 Mn |
| Jul 31, 2023 | 7.83 Mn |
| Apr 30, 2023 | 7.83 Mn |
| Jan 31, 2023 | 8.46 Mn |
| Oct 31, 2022 | 7.80 Mn |
| Jul 31, 2022 | 8.41 Mn |
| Apr 30, 2022 | 9.18 Mn |
| Jan 31, 2022 | 7.93 Mn |
| Oct 31, 2021 | 7.59 Mn |
| Jul 31, 2021 | 7.42 Mn |